Sponsored by:

Presented by:

Next-generation sequencing (NGS) applications for SARS-CoV-2 detection and surveillance

Now Available On-Demand

Your details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)



If you've already registered, please click here to log in to the webcast

Genomics is transforming modern infectious disease testing and surveillance, and expanding our understanding of pathogen evolution, and antibiotic resistance. In turn, public health professionals are changing the methods they use to research, monitor, and prevent epidemics and pandemics of high-profile infectious diseases such as influenza, tuberculosis, Ebola, and more recently, coronavirus.

In this webcast, the speaker will review the broad applicability of NGS for responding to the SARS-CoV-2 pandemic, from initial detection and characterization of the novel coronavirus to monitoring, surveillance and diagnostic detection. Illumina NGS provides workflow and analysis solutions across the clinical and public health continuum.

  • The value of genomics in the COVID-19 pandemic
  • How NGS can be applied to support surveillance and detection/diagnostic efforts
  • Information NGS can provide versus other conventional methods such as PCR
This webcast has been produced for Illumina, Inc. by Nature Research Custom Media. The sponsor retains sole responsibility for content. About this content.


Kelly Hoon
Infectious Disease Specialist
View Biography
Dr. Jayshan Carpen
Springer Nature
View Biography